Login to Your Account

Sosei buys into Mina's small activating RNAs in potential $536M deal

By Cormac Sheridan
Staff Writer

Wednesday, May 3, 2017

DUBLIN – Sosei Group is paying £35 million for a 25.6 percent stake in Mina Therapeutics Ltd. in a deal that gives it a commanding view of the emerging field of small activating RNA therapeutics.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription